Allergy/Immunology - Hematology/Oncology News & Articles

1 Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study Cancer Immunology, Immunotherapy, May 17, 2012    Clinical Article

2 Sunitinib-Induced Autoimmune Thyroiditis in a Patient with Metastatic Renal Cell Carcinoma: A Case Report Chemotherapy, May 17, 2012    Clinical Article

3 Dendritic Cell–Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells Clinical Cancer Research, May 16, 2012

4 Phenotypic and functional characteristics of ATP-hydrolysing CD4+CD39+ FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in patients with cancer European Journal of Immunology, May 16, 2012

5 Siglec-7 tetramers characterize B-cell subpopulations and leukemic blasts European Journal of Immunology, May 16, 2012

6 Intravenous immunoglobulin does not increase FcRIIB expression levels on monocytes in children with immune thrombocytopenic purpura Clinical and Experimental Immunology, May 15, 2012

7 Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor European Journal of Immunology, May 15, 2012

8 Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients European Journal of Immunology, May 15, 2012

9 Phase I trial of glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma showed immunological evidence and potential for improving overall survival Clinical Cancer Research, May 14, 2012    Clinical Article

10 Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination Cancer Immunology, Immunotherapy, May 14, 2012

11 Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma Cancer Immunology, Immunotherapy, May 14, 2012

12 Will vaccinated women attend cervical screening- A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia Cancer Epidemiology, May 14, 2012

13 Targeting macrophages in the tumor environment to enhance the efficacy of OX40 therapy Immunology, May 14, 2012

14 Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells European Journal of Immunology, May 11, 2012

15 Dual action of chronic ethanol treatment on LPS-induced response in C6 glioma cells Journal of Neuroimmunology, May 10, 2012

16 Functional Changes in Myeloid-Derived Suppressor Cells (MDSCs) during Tumor Growth: FKBP51 Contributes to the Regulation of the Immunosuppressive Function of MDSCs Journal of Immunology, May 9, 2012

17 A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma British Journal of Haematology, May 9, 2012

18 Enhancing Immunostimulatory Function of Human Embryonic Stem Cell-Derived Dendritic Cells by CD1d Overexpression Journal of Immunology, May 9, 2012

19 Sublytic Complement Protects Prostate Cancer Cells from TNF--Induced Cell Death Clinical and Experimental Immunology, May 7, 2012

20 The Next Challenge in Cancer Immunotherapy: Controlling T-Cell Traffic to the Tumor Cancer Research, May 4, 2012

1 The three main stumbling blocks for anticancer T cells Trends in Immunology, March 28, 2012

2 Heat Shock Protein 90-Mediated Peptide-Selective Presentation of Cytosolic Tumor Antigen for Direct Recognition of Tumors by CD4+ T Cells Journal of Immunology, April 10, 2012

3 Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease Cancer Immunology, Immunotherapy, April 9, 2012

4 MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition Journal of Experimental Medicine, April 11, 2012

5 CD73: a potent suppressor of antitumor immune responses Trends in Immunology, April 12, 2012

6 Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients Cancer, April 16, 2012

7 Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes International Journal of Cancer, April 30, 2012

8 Colonic Epithelial Cells Express Specific Ligands for Mucosal Macrophage Immunosuppressive Receptors Siglec-7 and -9 Journal of Immunology, April 23, 2012

9 Human V{γ}9V{δ}2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts Journal of Immunology, April 20, 2012

10 Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis Journal of Clinical Oncology, April 25, 2012